PHARMADAX INC. Inactive Instrument
Pharmadax Inc. Stock
Equities
4191
TW0004191002
Biotechnology & Medical Research
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Hsing Mei Ti
DFI | Director of Finance/CFO | - | 16-10-31 |
Hui Ju Chan
PSD | President | - | 12-02-29 |
Su Hsia Liao
PRN | Corporate Officer/Principal | - | 10-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yao Tang Chung
BRD | Director/Board Member | - | 13-09-26 |
Hui Ju Chan
PSD | President | - | 12-02-29 |
Hung Chi Huang
BRD | Director/Board Member | - | 12-12-23 |
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
| 1st Jan change | Capi. | |
|---|---|---|
| +21.74% | 46.4B | |
| -0.97% | 41.75B | |
| +49.62% | 41.37B | |
| -3.52% | 29.71B | |
| +11.12% | 26.01B | |
| -19.37% | 19.52B | |
| +31.18% | 12.43B | |
| -0.04% | 12.13B | |
| +0.39% | 12.18B |
